| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.06 |